| 7/5/2024 | PF | Fortress Biotech pauses dividend payments on 9.375% preferreds
|
| 10/12/2020 | PF | Market Commentary: Morning Commentary: Public Storage preferreds gain; Truist dips; Fortress Biotech sinks
|
| 8/27/2020 | PF | Market Commentary: Morning Commentary: Fortress rises; JPMorgan preferreds declining; Allstate active
|
| 8/26/2020 | PF | New Issue: Fortress Biotech prices $12 million add-on to 9.375% preferreds
|
| 8/24/2020 | PF | Market Commentary: Morning Commentary: Fortress to sell more preferreds; U.S. Bancorp trails; Argo gains
|
| 8/24/2020 | PF | Fortress Biotech to sell more cumulative perpetual preferred stock
|
| 5/27/2020 | PF | Market Commentary: Morning Commentary: $25-par market bustles; Brighthouse off; Pennsylvania REIT lower
|
| 5/27/2020 | PF | New Issue: Fortress Biotech prices $10 million add-on to 9.375% preferreds
|
| 5/22/2020 | PF | Market Commentary: Truist exercises $75 million 5.25% greenshoe; Brighthouse, First Horizon gain
|
| 5/21/2020 | PF | Market Commentary: Markel, CenterState, American Financial price; First Horizon preferreds flat; Brighthouse up
|
| 5/21/2020 | PF | Market Commentary: Morning Commentary: American Financial, Markel to tap primary market; preferreds mixed
|
| 5/20/2020 | PF | Market Commentary: Comerica prices; First Horizon offers preferreds; Brighthouse, Fortress improve; Truist flat
|
| 5/20/2020 | PF | Market Commentary: Morning Commentary: Comerica, First Horizon offer new preferred shares; preferreds gain
|
| 5/19/2020 | PF | Market Commentary: Truist sells $500 million preferreds; Fortress plans reopening; Comerica wraps investor calls
|
| 5/19/2020 | PF | Fortress Biotech markets add-on to 9.375% $25-par series A perpetual preferred stock
|
| 3/23/2020 | LMPF | Fortress Biotech OK’s repurchase of $5 million 9.375% preferreds
|
| 2/24/2020 | PF | Fortress greenshoe ups 9.375% perpetual preferreds to $14.38 million
|
| 2/12/2020 | PF | Market Commentary: Morning Commentary: Fortress Biotech prices; AT&T in pipeline; New Residential under par
|
| 2/12/2020 | PF | New Issue: Fortress sells $12.5 million more 9.375% cumulative preferreds
|
| 1/27/2020 | PF | Market Commentary: Morning Commentary: Fortress Biotech on tap; MetLife weaker; Wells Fargo declines
|
| 1/27/2020 | PF | Fortress Biotech to sell more $25-par 9.375% cumulative preferreds
|
| 11/26/2019 | PF | Market Commentary: Morning Commentary: First Republic prices; AXA gains; Ready Capital under pressure
|
| 11/26/2019 | PF | New Issue: Fortress Biotech add-on to 9.375% cumulative preferred shares raises $5.25 million
|
| 11/25/2019 | PF | New Issue: Fortress Biotech sells $5.25 million add-on to 9.375% series A perpetual preferred stock
|
| 11/12/2019 | PF | Market Commentary: Post-holiday preferreds mixed; Fortress Biotech, Goldman Sachs, American Equity offer deals
|
| 11/12/2019 | PF | Market Commentary: Morning Commentary: Preferreds stronger in after-holiday trade; Fortress Biotech on tap
|
| 11/12/2019 | PF | Fortress Biotech offers additional shares of 9.375% $25-par series A perpetual preferred stock
|
| 4/6/2018 | PF | Market Commentary: Cherry Hill, Fortress Biotech mixed after registering offerings; Allstate ends week down
|
| 4/5/2018 | PF | Market Commentary: Cherry Hill, Fortress Biotech plan more preferreds; Allstate’s recent issue trades up
|
| 4/5/2018 | PF | New Issue: Fortress Biotech offers $26 million at-the-market issue of 9.375% preferreds
|
| 11/7/2017 | PF | Market Commentary: Preferreds edge up; Fortress prices; SunTrust, BBVA, BNP eye deals; Rexford, AT&T up
|
| 11/7/2017 | PF | Market Commentary: Morning Commentary: Fortress prices preferreds; SunTrust, BBVA, BNP in pipeline; AT&T improves
|
| 11/7/2017 | PF | New Issue: Fortress sells $25 million 9.375% cumulative redeemable preferreds
|
| 11/2/2017 | PF | Market Commentary: Morning Commentary: Summit Hotel offers series E preferreds; Summit’s existing preferreds mixed
|
| 11/1/2017 | PF | Market Commentary: Preferreds mixed; Fortress Biotech offers perpetual preferreds; Plymouth Industrial dips
|
| 11/1/2017 | PF | Market Commentary: Morning Commentary: Fortress Biotech offers perpetual preferreds; Morgan Stanley, JPMorgan better
|
| 11/1/2017 | PF | Fortress Biotech to price series A cumulative redeemable preferreds
|
